|
Product class:
|
Authorized package
|
|
Medicinal product class:
|
For human use
|
|
Package code:
|
1150018
|
|
Name of medicinal product:
|
5-FLUOROURACIL "EBEWE"
|
|
Active substances:
|
|
|
ATC code:
|
L01BC02
|
|
Dosage form:
|
solution for injection/infusion
|
|
Route of administration:
|
intravenous use; intraarterial use
|
|
Strengh:
|
50mg 1ml
|
|
Amount in package:
|
10ml 5TK
|
|
Legal status for supply*:
|
Subject to medicinal prescription
|
|
Class of active substance:
|
|
|
Additional information:
|
|
|
Indication:
|
Colorectal, rectal, breast, gastric, pancreatic, hepatic, uterine, ovarian and bladder carcinoma.
|
|
Safety features:
|
Yes
|
|
Summary of product characteristics (SPC):
|
 (last updated January 31, 2022)
|
|
Package information leaflet (PIL):
|
EST (last updated January 31, 2022)
|
|
Labelling:
|
(last updated November 12, 2020)
|
|
Last imported to Estonia:
|
July 9, 2010
|
|
Marketing authorization holder:
|
Sandoz Pharmaceuticals d.d.
|
|
Marketing authorization number:
|
245099
|
|
Marketing authorization issued on:
|
February 26, 1999
|
|
Marketing authorization expires on:
|
Unlimited
|
|
Marketing authorization procedure type:
|
National
|
|
Reference price:
|
|
|
Under reference price:
|
|
|
Reference price of daily dose:
|
|
Entry/Changing date:
January 31, 2022
Legal status for supply – medicinal product on medical prescription or not subject to medical prescription
You can download Acrobat Reader fromhere